Feeling generally unwell or having flu-like symptomsBut if they persist for more than two weeks, you should see a GP.
A spokesperson for Cancer Research UK said: "Even if you're worried about what the symptom might be, don't delay seeing them."The symptom might not be due to cancer. But if it is, the earlier it's picked up the higher the chance of successful treatment.Around 6,200 people are diagnosed with cancer that starts in the liver each year in the UK. That’s 17 new cases every day.
It is more common in men than in women, and the risk of developing the disease gets higher as we get older, according to CRUK.The liver is the second largest organ in the body after your skin and sits just below your right lung.to other areas of the body.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
SGLT2 inhibitors can reduce the incidence of abnormal blood glucose caused by statins in non-diabetes patients with HFrEF after PCI - BMC Cardiovascular DisordersBackground Taking statins for a long time is associated with an increased risk of new-onset diabetes mellitus. Sodium-glucose cotransporter-2 (SGLT2) inhibitors can reduce insulin resistance and improve pancreatic β-cell function. Methods and results In total, 333 non-diabetes patients with heart failure with reduced ejection fraction (HFrEF) after percutaneous coronary intervention (PCI) are included. The enrolled patients are divided into a matched group (n = 198) and an SGLT2 inhibitors group (n = 135). There are no statistical differences in general information between the two groups before treatment. After a mean follow-up time of 13 months, abnormal blood glucose levels are significantly higher in the matched group than in the SGLT2 inhibitors group (6.06 vs. 0.74%, P | 0.05). There are no statistically significant differences in the alanine aminotransferase (ALT), uric acid (UA), and estimated glomerular filtration (eGFR) levels between the two groups. Conclusion SGLT2 inhibitors play a significant protective role in reducing the risk of statins-induced abnormal blood glucose in non-diabetes patients with HFrEF after PCI, without increasing the burden on the heart, kidneys, and liver.
Source: BioMedCentral - 🏆 22. / 71 Read more »